Cargando…
Friend or Foe: S100 Proteins in Cancer
S100 proteins are widely expressed small molecular EF-hand calcium-binding proteins of vertebrates, which are involved in numerous cellular processes, such as Ca(2+) homeostasis, proliferation, apoptosis, differentiation, and inflammation. Although the complex network of S100 signalling is by far no...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465620/ https://www.ncbi.nlm.nih.gov/pubmed/32722137 http://dx.doi.org/10.3390/cancers12082037 |
_version_ | 1783577628496625664 |
---|---|
author | Allgöwer, Chantal Kretz, Anna-Laura von Karstedt, Silvia Wittau, Mathias Henne-Bruns, Doris Lemke, Johannes |
author_facet | Allgöwer, Chantal Kretz, Anna-Laura von Karstedt, Silvia Wittau, Mathias Henne-Bruns, Doris Lemke, Johannes |
author_sort | Allgöwer, Chantal |
collection | PubMed |
description | S100 proteins are widely expressed small molecular EF-hand calcium-binding proteins of vertebrates, which are involved in numerous cellular processes, such as Ca(2+) homeostasis, proliferation, apoptosis, differentiation, and inflammation. Although the complex network of S100 signalling is by far not fully deciphered, several S100 family members could be linked to a variety of diseases, such as inflammatory disorders, neurological diseases, and also cancer. The research of the past decades revealed that S100 proteins play a crucial role in the development and progression of many cancer types, such as breast cancer, lung cancer, and melanoma. Hence, S100 family members have also been shown to be promising diagnostic markers and possible novel targets for therapy. However, the current knowledge of S100 proteins is limited and more attention to this unique group of proteins is needed. Therefore, this review article summarises S100 proteins and their relation in different cancer types, while also providing an overview of novel therapeutic strategies for targeting S100 proteins for cancer treatment. |
format | Online Article Text |
id | pubmed-7465620 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74656202020-09-04 Friend or Foe: S100 Proteins in Cancer Allgöwer, Chantal Kretz, Anna-Laura von Karstedt, Silvia Wittau, Mathias Henne-Bruns, Doris Lemke, Johannes Cancers (Basel) Review S100 proteins are widely expressed small molecular EF-hand calcium-binding proteins of vertebrates, which are involved in numerous cellular processes, such as Ca(2+) homeostasis, proliferation, apoptosis, differentiation, and inflammation. Although the complex network of S100 signalling is by far not fully deciphered, several S100 family members could be linked to a variety of diseases, such as inflammatory disorders, neurological diseases, and also cancer. The research of the past decades revealed that S100 proteins play a crucial role in the development and progression of many cancer types, such as breast cancer, lung cancer, and melanoma. Hence, S100 family members have also been shown to be promising diagnostic markers and possible novel targets for therapy. However, the current knowledge of S100 proteins is limited and more attention to this unique group of proteins is needed. Therefore, this review article summarises S100 proteins and their relation in different cancer types, while also providing an overview of novel therapeutic strategies for targeting S100 proteins for cancer treatment. MDPI 2020-07-24 /pmc/articles/PMC7465620/ /pubmed/32722137 http://dx.doi.org/10.3390/cancers12082037 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Allgöwer, Chantal Kretz, Anna-Laura von Karstedt, Silvia Wittau, Mathias Henne-Bruns, Doris Lemke, Johannes Friend or Foe: S100 Proteins in Cancer |
title | Friend or Foe: S100 Proteins in Cancer |
title_full | Friend or Foe: S100 Proteins in Cancer |
title_fullStr | Friend or Foe: S100 Proteins in Cancer |
title_full_unstemmed | Friend or Foe: S100 Proteins in Cancer |
title_short | Friend or Foe: S100 Proteins in Cancer |
title_sort | friend or foe: s100 proteins in cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465620/ https://www.ncbi.nlm.nih.gov/pubmed/32722137 http://dx.doi.org/10.3390/cancers12082037 |
work_keys_str_mv | AT allgowerchantal friendorfoes100proteinsincancer AT kretzannalaura friendorfoes100proteinsincancer AT vonkarstedtsilvia friendorfoes100proteinsincancer AT wittaumathias friendorfoes100proteinsincancer AT hennebrunsdoris friendorfoes100proteinsincancer AT lemkejohannes friendorfoes100proteinsincancer |